Annual EBITDA
$1.07B$43.00M+4.19%
Summary
- Current Value
- As of today, HSIC annual EBITDA is $1.07B, up +4.19% on
- Historical Performance
- HSIC annual EBITDA is down -7.04% over the past 3 years, up +41.98% over the past 5 years
- All-Time High Comparison
- HSIC annual EBITDA is currently -7.04% below its historical high of $1.15B set on
- 3-Year Low Comparison
- HSIC annual EBITDA is +11.12% above its 3-year low of $962.00M reached on
- Sector Comparison
- HSIC annual EBITDA is higher than 93.29% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $1.07B | +4.2% | -7.0% | +42.0% | +67.8% | |
| Quarterly EBITDA | $279.00M | +1.4% | +8.6% | -1.1% | +82.8% | |
| TTM EBITDA | $1.11B | +3.4% | +5.5% | +36.6% | +70.4% | |
| Price | $86.20 | +24.8% | +7.9% | +13.8% | +203.4% | |
| PE Ratio | 26.03 | +17.1% | +11.1% | +45.3% | +72.7% | |
| Annual Revenue | $13.18B | +4.0% | +4.3% | +30.3% | +75.2% | |
| Annual EPS | $3.27 | +7.1% | -16.3% | +16.6% | +87.4% | |
| $758.00M | +4.0% | -19.2% | +33.6% | +41.5% | ||
| Annual Net Income | $419.00M | +5.3% | -26.0% | +0.5% | +19.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $1.15B | N/A | -7.0% |
| 5Y | $1.15B | -7.0% | |
| All | $1.15B | -7.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $962.00M | +11.1% | |
| 5Y | $752.93M | N/A | +42.0% |
| All | -$5.70M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of HSIC?
As of today, HSIC annual EBITDA is $1.07B
What is 1-year change in HSIC annual EBITDA?
HSIC annual EBITDA is up +4.19% year-over-year
What is 3-year change in HSIC annual EBITDA?
HSIC annual EBITDA is down -7.04% over the past 3 years
How far is HSIC annual EBITDA from its all-time high?
HSIC annual EBITDA is currently -7.04% below its historical high of $1.15B set on December 31, 2022
How does HSIC annual EBITDA rank versus sector peers?
HSIC annual EBITDA is higher than 93.29% of companies in Healthcare sector
When is HSIC next annual earnings release?
As of today, the next annual earnings release for HSIC has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$279.00M$11.00M-3.79%
Summary
- Current Value
- As of today, HSIC quarterly EBITDA is $279.00M, down -3.79% on
- Historical Performance
- HSIC quarterly EBITDA is up +1.45% year-over-year, up +8.56% over the past 3 years
- All-Time High Comparison
- HSIC quarterly EBITDA is currently -6.69% below its historical high of $299.00M set on
- 3-Year Low Comparison
- HSIC quarterly EBITDA is +117.97% above its 3-year low of $128.00M reached on
- Sector Comparison
- HSIC quarterly EBITDA is higher than 93.34% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $279.00M | -3.8% | +1.4% | +8.6% | -1.1% | |
| Annual EBITDA | $1.07B | – | +4.2% | -7.0% | +42.0% | |
| TTM EBITDA | $1.11B | +0.4% | +3.4% | +5.5% | +36.6% | |
| Price | $86.20 | +8.9% | +24.8% | +7.9% | +13.8% | |
| PE Ratio | 26.03 | +8.9% | +17.1% | +11.1% | +45.3% | |
| Quarterly Revenue | $3.37B | -2.0% | +6.3% | +10.1% | +15.2% | |
| Quarterly EPS | $0.92 | +8.0% | +4.6% | +1.4% | -20.4% | |
| $150.00M | -27.9% | -25.7% | -26.8% | -35.6% | ||
| Quarterly Net Income | $112.00M | +8.7% | -0.9% | -12.5% | -36.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $290.00M | -3.8% | |
| 3Y | $290.00M | -3.8% | |
| 5Y | $299.00M | -6.7% | |
| All | $299.00M | -6.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $251.00M | N/A | +11.2% |
| 3Y | $128.00M | +118.0% | |
| 5Y | $128.00M | +118.0% | |
| All | -$398.30M | +170.1% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of HSIC?
As of today, HSIC quarterly EBITDA is $279.00M
What is HSIC quarterly EBITDA most recent change?
HSIC quarterly EBITDA was down -3.79% on March 28, 2026
What is 1-year change in HSIC quarterly EBITDA?
HSIC quarterly EBITDA is up +1.45% year-over-year
How far is HSIC quarterly EBITDA from its all-time high?
HSIC quarterly EBITDA is currently -6.69% below its historical high of $299.00M set on March 31, 2022
How does HSIC quarterly EBITDA rank versus sector peers?
HSIC quarterly EBITDA is higher than 93.34% of companies in Healthcare sector
When is HSIC next earnings release?
The next earnings release for HSIC is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$1.11B$4.00M+0.36%
Summary
- Current Value
- As of today, HSIC TTM EBITDA is $1.11B, up +0.36% on
- Historical Performance
- HSIC TTM EBITDA is up +3.36% year-over-year, up +5.53% over the past 3 years
- All-Time High Comparison
- HSIC TTM EBITDA is currently -0.08% below its historical high of $1.11B set on
- 3-Year Low Comparison
- HSIC TTM EBITDA is +24.55% above its 3-year low of $888.00M reached on
- Sector Comparison
- HSIC TTM EBITDA is higher than 93.62% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $1.11B | +0.4% | +3.4% | +5.5% | +36.6% | |
| Annual EBITDA | $1.07B | – | +4.2% | -7.0% | +42.0% | |
| Quarterly EBITDA | $279.00M | -3.8% | +1.4% | +8.6% | -1.1% | |
| Price | $86.20 | +8.9% | +24.8% | +7.9% | +13.8% | |
| PE Ratio | 26.03 | +8.9% | +17.1% | +11.1% | +45.3% | |
| TTM Revenue | $13.38B | +1.5% | +5.6% | +6.8% | +26.1% | |
| TTM EPS | $3.31 | +1.3% | +2.9% | -5.5% | +8.3% | |
| $739.00M | -6.6% | -4.4% | -11.9% | +18.9% | ||
| TTM Net Income | $418.00M | -0.2% | +1.2% | -17.7% | -8.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.11B | at high | |
| 3Y | $1.11B | at high | |
| 5Y | $1.11B | -0.1% | |
| All | $1.11B | -0.1% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $1.07B | N/A | +3.1% |
| 3Y | $888.00M | +24.6% | |
| 5Y | $888.00M | +24.6% | |
| All | -$370.50M | +398.5% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of HSIC?
As of today, HSIC TTM EBITDA is $1.11B
What is HSIC TTM EBITDA most recent change?
HSIC TTM EBITDA was up +0.36% on March 28, 2026
What is 1-year change in HSIC TTM EBITDA?
HSIC TTM EBITDA is up +3.36% year-over-year
How far is HSIC TTM EBITDA from its all-time high?
HSIC TTM EBITDA is currently -0.08% below its historical high of $1.11B set on September 30, 2022
How does HSIC TTM EBITDA rank versus sector peers?
HSIC TTM EBITDA is higher than 93.62% of companies in Healthcare sector
When is HSIC next earnings release?
The next earnings release for HSIC is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- HSIC Official Website www.henryschein.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1000228/000100022826000013/0001000228-26-000013-index.htm
- HSIC Profile on Yahoo Finance finance.yahoo.com/quote/HSIC
- HSIC Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/hsic